MG132: Revision history


For any version listed below, click on its date to view it. For more help, see Help:Page history and Help:Edit summary. (cur) = difference from current version, (prev) = difference from preceding version, m = minor edit, → = section edit, ← = automatic edit summary

(newest | oldest) View (newer 50 | ) (20 | 50 | 100 | 250 | 500)

29 November 2023

8 November 2023

4 May 2023

23 March 2022

29 June 2021

4 June 2021

4 February 2021

16 September 2020

4 September 2020

  • curprev 12:5212:52, 4 September 2020Citation bot talk contribs 5,000 bytes −101 Add: s2cid, pmid, author pars. 1-1. Removed URL that duplicated unique identifier. Removed parameters. Some additions/deletions were actually parameter name changes. | You can use this bot yourself. Report bugs here. | Suggested by AManWithNoPlan | All pages linked from cached copy of User:AManWithNoPlan/sandbox2 | via #UCB_webform_linked undo

14 July 2020

23 June 2020

26 April 2020

18 April 2020

18 November 2019

30 June 2019

17 June 2019

16 June 2019

12 October 2018

17 April 2018

22 March 2018

16 March 2018

  • curprev 10:1110:11, 16 March 2018Oeckes talk contribs 2,965 bytes +663 I added two original publications that have reported the synthesis of peptide aldehydes (which preceeded the development of MG-132) and the first desription of MG-132 (Z-LLL-al) as an inhibitor of the proteasomes (which was named Calpain in that paper as early on the proteasome was described under several different names). I deleted the word "specific" as MG-132 is known to also also influence other cellular targets at high concentration and is a broad-spectrum inhibitor. Today subunit-specific inhibtors are being developed (e.g. KZR-616 or ONX 0914). Thus, the word specific would be confusing here. undo

26 April 2017

12 October 2016

1 September 2016

31 August 2016

16 August 2016

11 August 2016

24 April 2016

8 January 2016

24 November 2015

19 October 2015

2 October 2015

31 October 2014

20 October 2014

27 June 2014

3 June 2014

(newest | oldest) View (newer 50 | ) (20 | 50 | 100 | 250 | 500)